{
    "id": 16011,
    "cites": 19,
    "cited_by": 4,
    "reference": [
        "Adams AS, Soumerai SB, Ross-Degnan D. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The case for a Medicare drug coverage benefit: a critical review of the empirical evidence.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Annu Rev Public Health 2001;22: 49-61.",
        "Briesacher, B. A., B. Stuart, X. Ren, J. A. Doshi, and M. V. Wrobel. 2005. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Medicare beneficiaries and the impact of gaining prescription drug coverage on inpatient and physician spending.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Health Serv Res 40(5 Pt 1): 1279-96.",
        "Chandra, A., J. Gruber, and R. McKnight. 2007. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Patient cost \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c sharing, hospitalization offsets, and the design of optimal health insurance for the elderly.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d National Bureau of Economic Research working Paper 12972.",
        "Eppig, F. J. and G. S. Chulis. 1997. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Matching MCBS (Medicare Current Beneficiary Survey) and Medicare data: the best of both worlds.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Health Care Financ Rev 18(3): 211-29.",
        "Goldman, D. P., G. F. Joyce, and Y. Zheng. 2007. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Prescription drug cost sharing: associations with medication and medical utilization and spending and health.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d JAMA 298(1): 61-9.",
        "Hsu, J., M. Price, J. Huang, R. Brand, V. Fung, R. Hui, B. Fireman, J. P. Newhouse, and J. V. Selby. 2006. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Unintended consequences of caps on Medicare drug benefits.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d N Engl J Med 354(22): 2349-59.",
        "Johnson, R. E., M. J. Goodman, M. C. Hornbrook, and M. B. Eldredge. 1997. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The effect of increased prescription drug cost-sharing on medical care utilization and expenses of elderly health maintenance organization members.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Med Care 35(11): 1119-31.",
        "Khan, N. and R. Kaestner. 2009. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Effect of prescription drug coverage on the elderly's use of prescription drugs.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Inquiry 46(1): 33-45.",
        "Levy H, Weir DR. 2009. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Take-up of Medicare Part D: results from the Health and Retirement Study.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d J Gerontol B Psychol Sci Soc Sci Dec 24.",
        "Lichtenberg, F. R. and S. X. Sun. 2007. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The impact of Medicare Part D on prescription drug use by the elderly.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Health Aff (Millwood) 26(6): 1735-44.",
        "Lillard, L. A., J. Rogowski, and R. Kington. 1999. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Insurance coverage for prescription drugs: effects on use and expenditures in the Medicare population.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Med Care 37(9): 926-36.",
        "Madden JM, Graves AJ, Zhang F, Adams AS, Briesacher BA, Ross-Degnan D, Gurwitz JH, PierreJacques M, Safran DG, Adler GS, Soumerai SB. 2008. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d JAMA Apr 23;299(16): 1922-8.",
        "Piette, J. D., M. Heisler, and T. H. Wagner. 2004. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Problems paying out-of-pocket medication costs among older adults with diabetes.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Diabetes Care 27(2): 384-91.",
        "Safran DG, Neuman P, Schoen C, Kitchman MS, Wilson IB, Cooper B, Li A, Chang H, Rogers WH. 2005. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Prescription drug coverage and seniors: findings from a 2003 national survey.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Health Aff Jan-Jun;Suppl Web Exclusives:W5-152-W5-166.",
        "Shea, D. G., J. V. Terza, B. C. Stuart, and B. Briesacher. 2007. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Estimating the effects of prescription drug coverage for Medicare beneficiaries.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Health Serv Res 42(3 Pt 1): 933-49.",
        "Soumerai, S. B., D. Ross-Degnan, J. Avorn, T. McLaughlin, and I. Choodnovskiy. 1991. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d N Engl J Med 325(15): 1072-7.",
        "Yang, Z., D. B. Gilleskie, and E. C. Norton. 2004. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Prescription drugs, medical care, and health outcomes: a model of elderly health dynamics.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d National Bureau of Economic Research working paper 10964.",
        "Yin, W., A. Basu, J. X. Zhang, A. Rabbani, D. O. Meltzer, and G. C. Alexander. 2008. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The effect of the Medicare Part D prescription benefit on drug utilization and expenditures.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Ann Intern Med 148(3): 169-77.",
        "Zhang, Y., J. M. Donohue, J. P. Newhouse, and J. R. Lave. 2009. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The effects of the coverage gap on drug spending: a closer look at Medicare Part D.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Health Aff (Millwood) 28(2): w317-25."
    ]
}